Nomura Holdings
ORKA

Nomura Holdings’s Oruka Therapeutics ORKA Stock Holding History

Nomura Holdings’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-1
Closed -$2K – 2944
2013
Q4 		$2K Sell
1
-19
-95% -$43.8K ﹤0.01% 1954
2013
Q3 		$48K Buy
+20
New +$41.7K ﹤0.01% 2133

Other funds holding ORKA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RCM
Rotella Capital Management Bellevue, Washington $1.47M AUM 12.32% 1-Year Est. Return
AL
Airain Ltd St. Peter Port, Guernsey $2.26B AUM 12.43% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Nomura Holdings's ORKA Position: Q1 2014 in Review

Nomura Holdings sold out of Oruka Therapeutics (ORKA) in Q1 2014, closing a stake of 1 share — an estimated $2K sold.

Nomura Holdings first reported a position in ORKA in Q3 2013 and held it in 2 quarters. The position peaked at $48K in Q3 2013. 11 funds tracked by Wall St. Rank hold ORKA as of Q1 2014.

  • Nomura Holdings reported no remaining Oruka Therapeutics position as of Q1 2014 after selling out during the quarter.
  • Nomura Holdings sold 1 Oruka Therapeutics share in Q1 2014, an estimated $2K.
  • Nomura Holdings first reported a position in Oruka Therapeutics in Q3 2013 and held it in 2 quarters.
  • Nomura Holdings's Oruka Therapeutics position peaked at $48K in Q3 2013.
  • 11 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q1 2014.

Based on Nomura Holdings's 13F filing for Q1 2014, filed 14 May 2014.